Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy

Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy

Abstract Background Oncolytic virotherapy (OVT) is a promising anti-tumor modality that utilizes oncolytic viruses (OVs) to preferentially attack cancers rather than normal tissues. With the understanding particularly in the characteristics of viruses and tumor cells, numerous innovative OVs have be...

Full description

Bibliographic Details
Main Authors: Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin, Hong-Wu Xin
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Translational Medicine
Subjects:
Oncolytic virotherapy (OVT)
Oncolytic viruses (OVs)
Cancer
T-VEC
BiTA
Online Access:https://doi.org/10.1186/s12967-023-04360-8

Similar Items

Similar Items